Shijiazhuang No. 4 Pharmaceutical

China’s 7th national Volume-Based Procurement (VBP) round concluded with winning bids for 60 drug products worth over RMB4.4 billion ($651 million). The results, released by VBP authorities, show Shijiazhuang No. 4 Pharmaceutical Co. Ltd as the top contract winner, while six foreign firms secured deals totaling RMB76.7 million (1.7% of…